Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 30;11(1):7-17.
doi: 10.46582/jsrm.1101003. eCollection 2015.

Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use

Jean-François Kaux  1 , Pierre Drion  2 , Jean-Louis Croisier  3 , Jean-Michel Crielaard  1
Affiliations

Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use

Jean-François Kaux et al. J Stem Cells Regen Med. .

Abstract

Objectives: The restorative properties of platelets, through the local release of growth factors, are used in various medical areas. This article reviews fundamental and clinical research relating to platelet-rich plasma applied to tendinous lesions.

Materials and method: Articles in French and English, published between 1 January 2012 and 31 December 2014. dealing with PRP and tendons were searched for using the Medline and Scopus data bases.

Results: Forty-seven articles were identified which addressed pre-clinical and clinical studies: 27 relating to in vitro and in vivo animal studies and 20 relating to human studies. Of these, five addressed lateral epicondylitis, two addressed rotator cuff tendinopathies, ten dealt with patellar tendinopathies and three looked at Achilles tendinopathies.

Conclusions: The majority of pre-clinical studies show that PRP stimulates the tendon's healing process. However, clinical series remain more controversial and level 1, controlled, randomised studies are still needed.

Keywords: Growth Factors; PRP; Platelet-rich Plasma; Tendinopathy.

PubMed Disclaimer

References

    1. Kaux JF, Degrave N, Crielaard JM. Platelet rich plasma : traitement des tendinopathies chroniques ? Revue de la litterature. J Traumatol Sport. 2007;24((2)):99–102.
    1. Kaux JF, Forthomme B, Le Goff C, Crielaard JM, Croisier JL. Current Opinions on Tendinopathy. J Sports Sci Med. 2011;10((2)):238–53. - PMC - PubMed
    1. Wasterlain AS, Braun HJ, Harris AH, Kim HJ, Dragoo JL. The systemic effects of platelet-rich plasma injection. Am J Sports Med. 2013;41((1)):186–93. - PubMed
    1. Mei-Dan O, Lippi G, Sanchez M, Andia I, Maffulli N. Autologous platelet-rich plasma: a revolution in soft tissue sports injury management? Phys Sportsmed. 2010;38((4)):127–35. - PubMed
    1. de Vos RJ, van Veldhoven PL, Moen MH, Weir A, Tol JL, Maffulli N. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull. 2010;95:63–77. - PubMed